BDBM575596 US11459339, Example 129::diethyl 2,2'-((((((2,2'-dimethyl-[1,1'- biphenyl]-3,3'-diyl))bis(azanediyl))bis (carbonyl))bis(4-cyclopropylpyridine- 6,3-diyl))bis(methylene))bis (methylazanediyl))diacetate

SMILES CCOC(=O)CN(C)Cc1cnc(cc1C1CC1)C(=O)Nc1cccc(c1C)-c1cccc(NC(=O)c2cc(C3CC3)c(CN(C)CC(=O)OCC)cn2)c1C

InChI Key InChIKey=IWILFGLBYQAGNR-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 575596   

TargetProgrammed cell death 1 ligand/protein 1(Human)
Abbisko Therapeutics

US Patent
LigandPNGBDBM575596(US11459339, Example 129 | diethyl 2,2'-((((((2,2'-...)
Affinity DataIC50: 102nMAssay Description:The effect of compounds and positive compounds of the examples of the present invention on the interaction between PD-1 and PD-L1 was determined by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
US Patent